Gentherm Incorporated : Still a great upward potential
Entry price | Target | Stop-loss | Potential |
---|
US$46.45 |
US$0 |
US$42.45 |
-100% |
---|
Gentherm is trading in a bullish trend and several arguments are in favor of the continuation of this trend.
The company’s fundamentals are still strong. Sales are expected to increase by 18.2% this year at USD 782 millions. Analysts from Thomson Reuters consensus have largely revised upward their sales and EPS estimates. 2014 EPS should stand at USD 1.61 from only USD 0.94 last year.
From a technical viewpoint, the security is trading in a bullish trend in the short and the long term. Increasing moving averages let think there will be no reversal in the coming trading sessions. This growth should help to reach soon USD 51.
Therefore, taking into account the strong fundamentals and technical patterns, it seems opportune to take a long position on the current price, in order to benefit from this strong bullish trend. The target price will be USD 51. A stop loss will be placed under the USD 42.57 short term support, threshold that would invalidate this trading strategy.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.